Practice Committee of the American Society for Reproductive Medicine. Smoking and infertility. Fertil Steril. 2008;90(suppl 5):S254-S259.
Eichener SF, Timpe EM. Urinary-based ovulation and pregnancy: point-of-care testing. Ann Pharmacother. 2004;38:325-331.
Practice Committee of the American Society of Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99:63.
Balen AH, Anderson RA; Policy & Practice Committee of the BFS. Impact of obesity on female reproductive health: British Fertility Society Practice and Policy Guidelines. Hum Fertil (Camb). 2007;10:195-206.
Requena AH, Herrero J, Landeras J, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update. 2008;14:571-582.
Society of Obstetricians and Gynaecologists of Canada. Clinical practice guideline - ovulation induction in polycystic ovary syndrome. May 2010. http://sogc.org (last accessed 28 July 2016).
Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89:505-522.
Pandian Z, Akande VA, Harrild K, et al. Surgery for tubal infertility. Cochrane Database Syst Rev. 2008;(3):CD006415.
Hart RJ, Hickey M, Maouris P, et al. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2008;(2):CD004992.
Tsoumpou I, Kyrgiou M, Gelbaya TA, et al. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril. 2009;92:75-87.
Society of Obstetricians and Gynaecologists of Canada. Clinical practice guideline - advanced reproductive age and fertility. November 2011. http://www.sogc.org (last accessed 28 July 2016).
Anderson RA, Pickering S. The current status of preimplantation screening: British Fertility Society Practice and Policy Guidelines. Hum Fertil (Camb) 2008;11:71-75.
Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Criteria for number of embryos to transfer: a committee opinion. Fertil Steril. 2013;99:44-46.
1. Speroff L, Fritz MA. Female infertility. In: Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2005:1028.
2. Gupta S, Goldberg JM, Aziz N, et al. Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril. 2008;90:247-257.
3. American Society for Reproductive Medicine. Unexplained infertility. 2013. http://www.asrm.org/ (last accessed 28 July 2016).
4. Sciarra JJ. Infertility: a global perspective on the role of infections. Ann N Y Acad Sci. 1991;626:478-483.
5. Cahill DJ, Wardle PG. Management of infertility. BMJ. 2002;325:28-32.
6. Chandra A, Martinez GM, Mosher WD, et al. Fertility, family planning, and reproductive health of US women: data from the 2002 National Survey of Family Growth. Vital Health Stat 23. 2005;25:1-160.
7. Centers for Disease Control and Prevention. 2011 assisted reproductive technology national summary report. Available http://www.cdc.gov/ (last accessed 28 July 2016).
8. Smith S, Pfeifer SM, Collins JA. Diagnosis and management of female infertility. JAMA. 2003;290:1767-1770.
9. Baird DT, Collins J, Egozcue J, et al; ESHRE Capri Workshop Group. Fertility and ageing. Hum Reprod Update. 2005;11:261-276.
10. Tietze C. Reproductive span and rate of reproduction among Hutterite women. Fertil Steril. 1957;8:89-97.
11. Schwartz D, Mayaux MJ, The Federation des Centres d'Etude et de Conservation du Sperme-Humain. Female fecundity as a function of age. Results of artificial insemination in 2193 nulliparous women with azoospermic husbands. N Engl J Med. 1982;306:404-406.
12. Dechanet C, Anahory T, Mathieu Daude JC, et al. Effects of cigarette smoking on reproduction. Hum Reprod Update. 2011;17:76-95.
13. MG Hull, North K, Taylor H, et al. Delayed conception and active and passive smoking: the Avon Longitudinal Study of Pregnancy and Childhood Study Team. Fertil Steril. 2000;74:725-733.
14. Practice Committee of the American Society for Reproductive Medicine. Smoking and infertility. Fertil Steril. 2008;90(suppl 5):S254-S259.
15. Mantzoros CS. Role of leptin in reproduction. Ann N Y Acad Sci. 2000;900:174-183.
16. Moschos S, Chan JL, Mantzoros CS. Leptin and reproduction: a review. Fertil Steril. 2002;77:433-444.
17. Moran LJ, Noakes M, Clifton PM, et al. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:812-819.
18. Metwally M, Ledger WL, Li TC. Reproductive endocrinology and clinical aspects of obesity in women. Ann N Y Acad Sci. 2008;1127:140-146.
19. Golden NH, Jacobson MS, Schebendach J, et al. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med. 1997;151:16-21.
20. Chan JL, Mantzoros CS. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet. 2005;366:74-85.
21. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update. 1999;5:433-447.
22. den Hartog JE, Morre SA, Land JA. Chlamydia trachomatis-associated tubal factor subfertility: immunogenetic aspects and serological screening. Hum Reprod Update. 2006;12:719-730.
23. Westrom L. Sexually transmitted diseases and infertility. Sex Trans Dis. 1994;21(suppl 2):S32-S37.
24. Leyland NC, Awadalla AB, Rittenberg F. Endometriosis: Diagnosis and management. Journal of Endometriosis. 2010;2:107-134.
25. Abruzzo MA, Hassold TJ. Etiology of nondisjunction in humans. Environ Mol Mutagen. 1995;28:167-175.
26. Battaglia DE, Goodwin P, Klein NA, et al. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod. 1996;11:2217-2222.
27. Keefe DL, Liu L, Marquard K. Telomeres and aging-related meiotic dysfunction in women. Cell Mol Life Sci. 2007:64;139-143.
28. Isaksson R, Tiitinen A. Present concept of unexplained infertility. Gynecol Endocrinol. 2004;18:278-290.
29. Hassan MA, Lavery SA, Trew GH. Congenital uterine anomalies and their impact on fertility. Womens Health (Lond Engl). 2010;6:443-461.
30. van Noord-Zaadstra BM, Looman CW, Alsbach H, et al. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ. 1991;302:1361-1365.
31. Levine AH, Pomeroy JC, Wilson TA. Hypothalamic dysfunction at ideal body weight simulating anorexia nervosa. J Pediatr Endocrinol. 1994;7:357-360.
32. Cooper GS, Baird DD, Hulka BS, et al. Follicle-stimulating hormone concentrations in relation to active and passive smoking. Obstet Gynecol. 1995;85:407-411.
33. Adena MA, Gallagher HG. Cigarette smoking and the age at menopause. Ann Hum Biol. 1982;9:121-130.
34. Sauer MA, Rifka SM, Hawks RL, et al. Marijuana: interaction with the estrogen receptor. J Pharmacol Exp Ther. 1983;224:404-407.
35. Reichman ME, Judd JT, Longcope C, et al. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J National Cancer Institute. 1993;83:722-727.
36. Hakim RB, Gray RH, Zacur H. Alcohol and caffeine consumption and decreased fertility. Fertil Steril. 1998;70:632-637.
37. Homan GF, Davies M, Norman R. The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review. Hum Reprod Update. 2007;13:209-223.
38. Bolumar F, Olsen J, Rebagliato M, et al. Caffeine intake and delayed conception: a European multicenter study on infertility and subfecundity. European Study Group on Infertility Subfecundity. Am J Epidemiol. 1997;145:324-334.
39. Hassan MA, Killick SR. Negative lifestyle is associated with a significant reduction in fecundity. Fertil Steril. 2004;81:384-392.
40. Signorello LB, McLaughlin JK. Maternal caffeine consumption and spontaneous abortion: a review of the epidemiologic evidence. Epidemiology. 2004;15:229-239.
41. Cwikel J, Gidron Y, Sheiner E. Psychological interactions with infertility among women. Eur J Obstet Gynecol Reprod Biol. 2004;117:126-131.
42. Downey J, McKinney M. The psychiatric status of females presenting for infertility evaluation. Am J Orthopsychiatry. 1992;62:196-205.
43. Cousinea TM, Green TC, Corsini EA, et al. Development and validation of the Infertility Self-Efficacy Scale. Fertil Steril. 2006;85:1684-1696.
44. Hjollund NH, Jensen TK, Bonde JP, et al. Distress and reduced fertility: a follow-up study of first-pregnancy planners. Fertil Steril. 1999;72:47-53.
45. Domar AD, Clapp D, Slawsby EA, et al. Impact of group psychological interventions on pregnancy rates in infertile women. Fertil Steril. 2000;73:805-811.
46. Luderer U, Hieb M, Diaz J, et al. Reproductive and developmental hazard management guidance: ACOEM Task Force on Reproductive Toxicology. J Occup Environ Med. 2011;53:941-949.
47. Eichener SF, Timpe EM. Urinary-based ovulation and pregnancy: point-of-care testing. Ann Pharmacother. 2004;38:325-331.
48. Coutifaris C, Myers ER, Guzick DS, et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril. 2004;82:1264-1272.
49. Mohiyiddeen L, Hardiman A, Fitzgerald C, et al. Tubal flushing for subfertility. Cochrane Database Syst Rev. 2015;(5):CD003718.
50. Saunders RD, Shwayder JM, Nakajima ST. Current methods of tubal patency assessment. Fertil Steril. 2011;95:2171-2179.
51. Sylvestre C, Child TJ, Tulandi T, et al. A prospective study to evaluate the efficacy of two- and three-dimensional sonohysterography in women with intrauterine lesions. Fertil Steril. 2003;79:1222-1225.
52. Coyne L, Jayaprakasan K, Raine-Fenning N. 3D ultrasound in gynecology and reproductive medicine. Womens Health (Lond Engl). 2008;4:501-516.
53. Pellerito JS, McCarthy SM, Doyle MB, et al. Diagnosis of uterine anomalies: relative accuracy of MR imaging, endovaginal sonography, and hysterosalpingography. Radiology. 1992;183:795-800.
54. Olpin JD, Heilbrun M. Imaging of Mullerian duct anomalies. Clin Obstet Gynecol. 2009;52:40-56.
55. Bosteels J, Weyers S, Puttemans P, et al. The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review. Hum Reprod Update. 2010;16:1-11.
56. El-Toukhy T, Campo R, Khalaf Y, et al. Hysteroscopy in recurrent in-vitro fertilisation failure (TROPHY): a multicentre, randomised controlled trial. Lancet. 2016;387:2614-2621.
57. Domingues TS, Rocha AM, Serafini PC. Tests for ovarian reserve: reliability and utility. Curr Opinion Obstet Gynecol. 2010;22:271-276.
58. La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113-130.
59. Maheshwari A, Bhattacharya S, Johnson NP. Predicting fertility. Hum Fertil (Camb). 2008;11:109-117.
60. Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685-718.
61. Keltz MD, Olive DL, Kim AH, et al. Sonohysterography for screening in recurrent pregnancy loss. Fertil Steril. 1997;67:670-674.
62. Sylvestre C, Child TJ, Tulandi T, et al. A prospective study to evaluate the efficacy of two- and three-dimensional sonohysterography in women with intrauterine lesions. Fertil Steril. 2003;79:1222-1225.
63. Practice Committee of the American Society of Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99:63.
64. Balen AH, Anderson RA; Policy & Practice Committee of the BFS. Impact of obesity on female reproductive health: British Fertility Society Practice and Policy Guidelines. Hum Fertil (Camb). 2007;10:195-206.
65. Anderson K, Norman RJ, Middleton P. Preconception lifestyle advice for people with subfertility. Cochrane Database Syst Rev. 2010;(4):CD008189.
66. Ahmad G, Watson A, Vanderkerchove P, et al. Techniques for pelvic surgery in subfertility. Cochrane Database Syst Rev. 2006;(2):CD000221.
67. Pritts EA. Letrozole for ovulation induction and controlled ovarian hyperstimulation. Curr Opin Obstet Gynecol. 2010;22:289-294.
68. Polyzos NP, Tzioras S, Badawy AM, et al. Aromatase inhibitors for female infertility: a systematic review of the literature. Reprod Biomed Online. 2009;19:456-471.
69. He D, Jiang F. Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome. Reprod Biomed Online. 2011;23:91-96.
70. Franik S, Kremer JA, Nelen WL, et al. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2014;(2):CD010287.
71. Eckmann KR, Kockler DR. Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome. Ann Pharmacother. 2009;43:1338-1346.
72. Requena AH, Herrero J, Landeras J, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update. 2008;14:571-582.
73. van Wely M, Kwan I, Burt AL, et al. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011;(2):CD005354.
74. van Rumste MME, Custers IM, van der Veen et al. The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. Hum Reprod Update. 2008;14:563-570.
75. Cousineau T, Domar A. Psychological impact of infertility. Best Pract Res Clin Obstet Gynaecol. 2007;21:293-308.
76. Hämmerli K, Znoj H, Barth J. The efficacy of psychological interventions for infertile patients: a meta-analysis examining mental health and pregnancy rate. Hum Reprod Update. 2009;15:279-295.
77. Verkuijlen J, Verhaak C, Nelen WL, et al. Psychological and educational interventions for subfertile men and women. Cochrane Database Syst Rev. 2016;3:CD011034.
78. Society of Obstetricians and Gynaecologists of Canada. Clinical practice guideline - ovulation induction in polycystic ovary syndrome. May 2010. http://sogc.org (last accessed 28 July 2016).
79. Nestler JE, Jakubowicz DJ, Evans WS, et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998;338:1876-1880.
80. Misso ML, Costello MF, Garrubba M, et al. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2013;19:2-11.
81. Johnson N. Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome - a meta-analysis of randomised trials. Aust N Z J Obstet Gynaecol. 2011;51:125-129.
82. Tang T, Lord JM, Norman RJ, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2012;(5):CD003053.
83. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89:505-522.
84. Farquhar C, Brown J, Marjoribanks J. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2012;(6):CD001122.
85. Fernandez H, Morin-Surruca M, Torre A, et al. Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review. Reprod Biomed Online. 2011;22:556-568.
86. Vause TD, Cheung AP, Sierra S, et al. Ovulation induction in polycystic ovary syndrome. J Obstet Gynaecol Can. 2010;32:495-502.
87. Pandian Z, Akande VA, Harrild K, et al. Surgery for tubal infertility. Cochrane Database Syst Rev. 2008;(3):CD006415.
88. Johnson N, van Voorst S, Sowter MC, et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev. 2010;(1):CD002125.
89. Hughes E, Brown J, Collins JJ, et al. Ovulation suppression for endometriosis for women with subfertility. Cochrane Database Syst Rev. 2007;(3):CD000155.
90. Duffy JM, Arambage K, Correa FJ, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2014;(4):CD011031.
91. Hart RJ, Hickey M, Maouris P, et al. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2008;(2):CD004992.
92. Society of Obstetricians and Gynaecologists of Canada. Clinical practice guideline - endometriosis: diagnosis and management. July 2010. http://www.sogc.org (last accessed 28 July 2016).
93. Tsoumpou I, Kyrgiou M, Gelbaya TA, et al. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril. 2009;92:75-87.
94. Benschop L, Farquhar C, van der Poel N, et al. Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev. 2010;(11):CD008571.
95. Saraswat L, Ayansina DT, Cooper KG, et al. Pregnancy outcomes in women with endometriosis: a national record linkage study. BJOG. 2016 Feb 16 [Epub ahead of print].
96. Society of Obstetricians and Gynaecologists of Canada. Clinical practice guideline - advanced reproductive age and fertility. November 2011. http://www.sogc.org (last accessed 28 July 2016).
97. ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update. 2009;15:265-277.
98. Steures P, van der Steeg JW, Hompes PG, et al. Intra-uterine insemination with controlled ovarian hyperstimulation compared to an expectant management in couples with unexplained subfertility and an intermediate prognosis: a randomised study [in Dutch]. Ned Tijdschr Geneeskd. 2008;152:1525-1531.
99. Bhattacharya S, Harrild K, Mollison J, et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: Pragmatic randomised controlled trial. BMJ. 2008;337:a716.
100. Hughes E, Brown J, Collins JJ, et al. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev. 2010;(1):CD000057.
101. Veltman-Verhulst SM, Hughes E, Ayeleke RO, et al. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2016;(2):CD001838.
102. Pandian Z, Gibreel A, Bhattacharya S. In vitro fertilisation for unexplained subfertility. Cochrane Database Syst Rev. 2012;(4):CD003357.
103. Nieuwenhuis-Ruifrok AE, Kuchenbecker WK, Hoek A, et al. Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis. Hum Reprod Update. 2009;15:57-68.
104. Custers IM, van Rumste MM, van der Steeg JW, et al. Long-term outcome in couples with unexplained subfertility and an intermediate prognosis initially randomized between expectant management and immediate treatment. Hum Reprod. 2012;27:444-450.
105. Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37-43.
106. Anderson RA, Pickering S. The current status of preimplantation screening: British Fertility Society Practice and Policy Guidelines. Hum Fertil (Camb) 2008;11:71-75.
107. Harton GL, Magli MC, Lundin K, et al. ESHRE PGD Consortium/Embryology Special Interest Group - best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod. 2011;26:41-46.
108. Brännström M, Johannesson L, Bokström H, et al. Livebirth after uterus transplantation. Lancet. 2015;385:607-616.
109. Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed). 1985;291:1693-1697.
110. Homburg R. Clomiphene citrate - end of an era? A mini-review. Hum Reprod. 2005;20:2043-2051.
111. Dickey RP. Strategies to reduce multiple pregnancies due to ovulation stimulation. Fertil Steril. 2009;91:1-17.
112. Zivi E, Simon A, Laufer N. Ovarian hyperstimulation syndrome: definition, incidence, and classification. Semin Reprod Med. 2010;28:441-447.
113. Royal College of Obstetricians and Gynaecologists. Multiple pregnancy following assisted reproduction. January 2011. http://www.rcog.org.uk (last accessed 28 July 2016).
114. Society of Obstetricians and Gynaecologists of Canada. Joint SOGC-CFAS clinical practice guideline: elective single embryo transfer following in vitro fertilization. April 2010. http://www.sogc.org (last accessed 28 July 2016).
115. Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Criteria for number of embryos to transfer: a committee opinion. Fertil Steril. 2013;99:44-46.
116. Kashyap S, Moher D, Fung MF, et al. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis. Obstet Gynecol. 2004;103:785-794.
117. Brinton LA, Lamb EJ, Moghissi KS, et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol. 2004;103:1194-1203.
118. Kallen B, Finnstrom O, Lindam A, et al. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod. 2011;26:253-258.
119. Gelbaya TA. Short and long-term risks to women who conceive through in vitro fertilization. Hum Fertil (Camb). 2010;13:19-27.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台